Chunguang yang (101937)
1 clinical trials · Sponsor
◉ Watch Chunguang yang (101937)
| Record | Firm | Date |
|---|---|---|
| Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma (NCT05723991) | Chunguang yang (101937) | 2022-09-28 |
Track Chunguang yang (101937) automatically
Every clearance here is in the API, with alerts when new ones post.